rs137852637
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_005518.4(HMGCS2):c.1270C>T(p.Arg424*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000527 in 1,612,718 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_005518.4 stop_gained
Scores
Clinical Significance
Conservation
Publications
- 3-hydroxy-3-methylglutaryl-CoA synthase deficiencyInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), PanelApp Australia, Orphanet, ClinGen, G2P
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| HMGCS2 | NM_005518.4 | c.1270C>T | p.Arg424* | stop_gained | Exon 7 of 10 | ENST00000369406.8 | NP_005509.1 | |
| HMGCS2 | NM_001166107.1 | c.1144C>T | p.Arg382* | stop_gained | Exon 6 of 9 | NP_001159579.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 151838Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000239 AC: 6AN: 251244 AF XY: 0.0000368 show subpopulations
GnomAD4 exome AF: 0.0000548 AC: 80AN: 1460880Hom.: 0 Cov.: 31 AF XY: 0.0000537 AC XY: 39AN XY: 726780 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000329 AC: 5AN: 151838Hom.: 0 Cov.: 32 AF XY: 0.0000270 AC XY: 2AN XY: 74156 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
3-hydroxy-3-methylglutaryl-CoA synthase deficiency Pathogenic:2
- -
This sequence change creates a premature translational stop signal (p.Arg424*) in the HMGCS2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in HMGCS2 are known to be pathogenic (PMID: 20346956, 23751782, 25511235). This variant is present in population databases (rs137852637, gnomAD 0.004%). This premature translational stop signal has been observed in individual(s) with HMG-CoA synthase deficiency (PMID: 11228257, 23751782). ClinVar contains an entry for this variant (Variation ID: 9258). For these reasons, this variant has been classified as Pathogenic. -
HMGCS2-related disorder Pathogenic:1
The HMGCS2 c.1270C>T variant is predicted to result in premature protein termination (p.Arg424*). This variant has been reported in individuals with mitochondrial HMG-CoA synthase deficiency (Patient 2, Bouchard et al. 2001. PubMed ID: 11228257; Table 2, Shafqat et al. 2010. PubMed ID: 20346956; Ramos et al. 2013. PubMed ID: 23751782). This variant is reported in 0.0040% of alleles in individuals of African descent in gnomAD (http://gnomad.broadinstitute.org/variant/1-120295927-G-A). Nonsense variants in HMGCS2 are expected to be pathogenic. This variant is interpreted as pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at